Literature DB >> 23664397

Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.

Mike Notohamiprodjo1, Michael Staehler, Nicole Steiner, Felix Schwab, Steven P Sourbron, Henrik J Michaely, Andreas D Helck, Maximilian F Reiser, Konstantin Nikolaou.   

Abstract

PURPOSE: To investigate a multiparametric magnetic resonance imaging (MRI) approach comprising diffusion-weighted imaging (DWI), blood oxygen-dependent (BOLD), and dynamic contrast-enhanced (DCE) MRI for characterization and differentiation of primary renal cell carcinoma (RCC).
MATERIAL AND METHODS: Fourteen patients with clear-cell carcinoma and four patients with papillary RCC were examined with DWI, BOLD MRI, and DCE MRI at 1.5T. The apparent diffusion coefficient (ADC) was calculated with a monoexponential decay. The spin-dephasing rate R2* was derived from parametric R2* maps. DCE-MRI was analyzed using a two-compartment exchange model allowing separation of perfusion (plasma flow [FP] and plasma volume [VP]), permeability (permeability surface area product [PS]), and extravascular extracellular volume (VE). Statistical analysis was performed with Wilcoxon signed-rank test, Pearson's correlation coefficient, and receiver operating characteristic curve analysis.
RESULTS: Clear-cell RCC showed higher ADC and lower R2* compared to papillary subtypes, but differences were not significant. FP of clear-cell subtypes was significantly higher than in papillary RCC. Perfusion parameters showed moderate but significant inverse correlation with R2*. VE showed moderate inverse correlation with ADC. Fp and Vp showed best sensitivity for histological differentiation.
CONCLUSION: Multiparametric MRI comprising DWI, BOLD, and DCE MRI is feasible for assessment of primary RCC. BOLD moderately correlates to DCE MRI-derived perfusion. ADC shows moderate correlation to the extracellular volume, but does not correlate to tumor oxygenation or perfusion. In this preliminary study DCE-MRI appeared superior to BOLD and DWI for histological differentiation.
Copyright © 2013 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23664397     DOI: 10.1016/j.acra.2013.01.015

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  11 in total

1.  Statistical clustering of parametric maps from dynamic contrast enhanced MRI and an associated decision tree model for non-invasive tumour grading of T1b solid clear cell renal cell carcinoma.

Authors:  Yin Xi; Qing Yuan; Yue Zhang; Ananth J Madhuranthakam; Michael Fulkerson; Vitaly Margulis; James Brugarolas; Payal Kapur; Jeffrey A Cadeddu; Ivan Pedrosa
Journal:  Eur Radiol       Date:  2017-07-05       Impact factor: 5.315

2.  [Cross-sectional imaging evaluation of renal masses].

Authors:  P Nuhn; A Sterzik; C G Stief; M Staehler; M D'Anastasi
Journal:  Urologe A       Date:  2015-07       Impact factor: 0.639

Review 3.  The role of functional imaging in the era of targeted therapy of renal cell carcinoma.

Authors:  Margarita Braunagel; Anno Graser; Maximilian Reiser; Mike Notohamiprodjo
Journal:  World J Urol       Date:  2013-04-16       Impact factor: 4.226

4.  Rethinking cancer nanotheranostics.

Authors:  Hongmin Chen; Weizhong Zhang; Guizhi Zhu; Jin Xie; Xiaoyuan Chen
Journal:  Nat Rev Mater       Date:  2017-05-09       Impact factor: 66.308

5.  Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.

Authors:  Mickael Tordjman; Rahul Mali; Guillaume Madelin; Vinay Prabhu; Stella K Kang
Journal:  Eur Radiol       Date:  2020-03-06       Impact factor: 5.315

Review 6.  Visualization, imaging and new preclinical diagnostics in radiation oncology.

Authors:  Clemens C Cyran; Philipp M Paprottka; Michel Eisenblätter; Dirk A Clevert; Carsten Rist; Konstantin Nikolaou; Kirsten Lauber; Frederik Wenz; Daniel Hausmann; Maximilian F Reiser; Claus Belka; Maximilian Niyazi
Journal:  Radiat Oncol       Date:  2014-01-03       Impact factor: 3.481

7.  Diagnostic Utility of Diffusion-weighted Magnetic Resonance Imaging in Differentiating Small Solid Renal Tumors (≤ 4 cm) at 3.0T Magnetic Resonance Imaging.

Authors:  Han-Mei Zhang; Ying-Hua Wu; Qi Gan; Xiao Lyu; Xiang-Lan Zhu; Min Kuang; Rong-Bo Liu; Zi-Xing Huang; Fang Yuan; Xi-Jiao Liu; Bin Song
Journal:  Chin Med J (Engl)       Date:  2015-06-05       Impact factor: 2.628

8.  Modified dixon-based renal dynamic contrast-enhanced MRI facilitates automated registration and perfusion analysis.

Authors:  Anneloes de Boer; Tim Leiner; Eva E Vink; Peter J Blankestijn; Cornelis A T van den Berg
Journal:  Magn Reson Med       Date:  2017-11-13       Impact factor: 4.668

9.  Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma.

Authors:  Hayley M Reynolds; Bimal K Parameswaran; Mary E Finnegan; Diana Roettger; Eddie Lau; Tomas Kron; Mark Shaw; Sarat Chander; Shankar Siva
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

Review 10.  Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma.

Authors:  Yan Wu; Young Suk Kwon; Mina Labib; David J Foran; Eric A Singer
Journal:  Dis Markers       Date:  2015-11-01       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.